What Is Dabbing and What Does It Do to Your Body
Product-Specific
90%
Dabbing delivers 60 to 90 percent THC in a single hit, and a 2019 study found concentrate users developed significantly higher tolerance and worse withdrawal than flower-only users.
Chan et al., Drug and Alcohol Dependence, 2019
Chan et al., Drug and Alcohol Dependence, 2019
View as imageDabbing has gone from a fringe practice to a mainstream cannabis consumption method in less than a decade. It involves flash-vaporizing cannabis concentrates on a superheated surface and inhaling the resulting vapor. The concentrates used typically contain 60% to 90% THC, compared to 15% to 30% in high-quality flower. The effect is immediate, intense, and qualitatively different from smoking a joint.
For some users, dabbing is the preferred consumption method because of its potency, flavor, and rapid onset. For others, it is the method that accelerated their tolerance, complicated their relationship with cannabis, or introduced health concerns they did not anticipate. This article covers the mechanics, the science, and the risks in plain terms.
Key Takeaways
- Dabbing means flash-vaporizing cannabis concentrates on a hot surface, delivering 60 to 90% THC in a single hit — compared to 15 to 30% in typical flower — so the effects are immediate and intense
- The extreme heat involved (300 to 700 degrees Fahrenheit) can create harmful byproducts like methacrolein and benzene, especially above 600 degrees Fahrenheit
- Tolerance builds fast with concentrates because your brain's CB1 receptors dial themselves down in response to huge THC doses — which is why regular dabbers often say flower "doesn't work anymore"
- The research on dabbing specifically is still limited, but the pharmacology is straightforward: higher doses of any psychoactive substance raise the risk of dependence, worse withdrawal, and bad psychological reactions
- Dabbing at lower temperatures (below 450 degrees Fahrenheit) cuts down on harmful byproducts but doesn't change the tolerance and dependence risks that come with high-potency THC
- A 2019 study by Chan et al. in Drug and Alcohol Dependence found that concentrate users had significantly higher tolerance, worse withdrawal, and used more often than flower-only users — exactly what you'd expect when the dose goes up
How Dabbing Works
Dabbing: Concentrate Types + Temperature Risks
Tolerance warning: Concentrate users had significantly higher tolerance, worse withdrawal, and used more often than flower-only users (Chan et al., Drug and Alcohol Dependence, 2019).
The basic mechanism is straightforward. A small amount of cannabis concentrate, typically the size of a grain of rice to a small pea, is placed on a heated surface and inhaled through a water pipe.
The traditional setup involves a dab rig, which looks like a small water pipe, fitted with a nail made of quartz, titanium, or ceramic. The nail is heated with a butane torch until it reaches the target temperature, then allowed to cool briefly. The concentrate is applied to the hot surface using a small metal tool called a dabber. It vaporizes on contact, and the vapor is pulled through the water pipe and into the lungs.
Electronic nails (e-nails) eliminate the torch by using an electrically heated coil that maintains a set temperature. This provides more consistent heating and reduces the risk of overheating the concentrate.
Electronic dab pens and portable e-rigs have made dabbing more accessible and discreet. These devices use battery-powered heating elements and pre-loaded or refillable chambers. They represent the fastest-growing segment of concentrate consumption.
The key difference between dabbing and smoking flower is concentration and delivery efficiency. When you smoke a bowl of flower, the combustion process is inefficient, and the THC content of the plant material is relatively low. When you dab a concentrate, you are delivering a massive dose of THC directly to the lungs in a single inhalation.
Concentrate Types
Not all concentrates are the same. They differ in extraction method, consistency, terpene content, and potency.
Shatter is a translucent, glass-like concentrate that breaks when handled. It is typically made through butane hash oil (BHO) extraction and has a relatively stable molecular structure. THC content usually ranges from 70% to 90%.
Wax has a softer, opaque consistency. It is made through similar extraction processes as shatter but with different post-processing that introduces air and disrupts the molecular structure. Potency is comparable to shatter.
Budder (or batter) has a creamy, butter-like texture. It is whipped during processing to create its consistency. Some users prefer it because it is easier to handle than shatter.
Live resin is extracted from fresh-frozen cannabis plants rather than dried and cured material. Freezing the plant immediately after harvest preserves a higher terpene content, producing a more flavorful product. Live resin typically has slightly lower THC than shatter or wax (60-80%) but a richer terpene profile.
Rosin is a solventless concentrate made by applying heat and pressure to cannabis flower or hash. Because no chemical solvents are used, some consumers consider it a cleaner option. Quality rosin can match the potency and terpene content of solvent-based concentrates.
Distillate is a highly refined concentrate that has been stripped of everything except THC (or CBD). It is essentially pure cannabinoid, often exceeding 90% THC, with no terpenes or other plant compounds unless they are added back. Distillate is commonly used in vape cartridges and edibles.
What Happens in Your Body
When you inhale a dab, THC crosses the thin membrane of the alveoli in your lungs and enters the bloodstream within seconds. From the blood, it reaches the brain in under 10 seconds. The entire process from inhalation to peak effect happens in 1 to 3 minutes.
The intensity is proportional to the dose. A single dab of a concentrate at 80% THC delivers roughly the same amount of THC as an entire joint of 20% flower, but in a single breath. The result is a rapid surge of THC binding to CB1 receptors in the brain, producing intense euphoria, altered perception, and cognitive impairment that can feel overwhelming, especially for users without established tolerance.
Peak blood THC levels from dabbing are substantially higher than from smoking flower. A 2017 study by Bidwell and colleagues at the University of Colorado measured blood THC concentrations after concentrate use and found levels roughly double those achieved by flower users, despite the concentrate users reporting similar levels of subjective intoxication, suggesting rapid tolerance compensation.
The duration of effects from a single dab is typically 1 to 3 hours, similar to smoking flower, though the peak intensity is greater. Some users report lingering grogginess or cognitive fog for several hours after dabbing, particularly with higher doses.
Temperature Science
Temperature is one of the most important variables in dabbing and one of the most commonly overlooked. The temperature at which you vaporize a concentrate determines what you inhale.
Low-temperature dabbing (300-450 degrees Fahrenheit) vaporizes cannabinoids and terpenes with minimal degradation. The vapor is smoother, more flavorful, and produces fewer harmful byproducts. Terpenes have different boiling points, so lower temperatures preserve the more volatile ones that contribute to flavor.
Medium-temperature dabbing (450-600 degrees Fahrenheit) produces thicker vapor and more intense effects. More of the concentrate is vaporized, increasing efficiency. Some terpene degradation occurs, and the risk of harmful byproduct formation increases.
High-temperature dabbing (above 600 degrees Fahrenheit) can produce harsh, hot vapor and significantly increases the formation of toxic compounds. A 2017 study by Meehan-Atrash and colleagues in ACS Omega analyzed the degradation products of terpenes at high temperatures and found that dabbing at temperatures above 600 degrees Fahrenheit produced methacrolein and benzene, both of which are known respiratory irritants and potential carcinogens.
The study specifically examined myrcene, limonene, linalool, and other common cannabis terpenes and found that all produced concerning degradation products at elevated temperatures. The concentrations increased dramatically above 600 degrees Fahrenheit.
This is why the trend toward low-temperature dabbing is not just an aesthetic preference. It is a harm reduction practice with a scientific basis. E-nails and temperature-controlled devices make consistent low-temperature dabbing achievable, while torch-based methods make it difficult to gauge the exact temperature of the nail surface.
Lung Health Concerns
The research on dabbing-specific lung effects is still limited. Cannabis smoking research provides some context, but dabbing introduces different variables: higher temperatures, different chemical compositions, and the absence of plant combustion products.
Concentrate vapor does not contain many of the harmful compounds found in smoked flower (tar, carbon monoxide, particulate matter from combustion). In theory, this should make it less damaging to the respiratory system. But the high-temperature degradation products discussed above introduce their own concerns, and the long-term effects of inhaling concentrated cannabinoid vapor are not well-studied.
The EVALI outbreak of 2019, which caused severe lung injuries in thousands of people, was traced primarily to illicit-market vape cartridges containing vitamin E acetate as a cutting agent. Dabbing flower-based concentrates (shatter, wax, rosin) from regulated markets is a different exposure profile. But the EVALI crisis illustrates how adulterants in concentrate products can cause serious harm, reinforcing the importance of purchasing from regulated sources with lab-tested products.
Anecdotal reports from heavy dabbers include chronic cough, increased mucus production, and throat irritation. Whether these symptoms reflect the concentrate itself, the temperature, frequency of use, or individual susceptibility is unclear without controlled studies.
Tolerance Acceleration
This is arguably the most significant practical concern with dabbing. Regular concentrate use accelerates tolerance development dramatically.
Tolerance to THC occurs because chronic activation of CB1 receptors triggers downregulation, your brain reduces the number and sensitivity of these receptors to compensate for the constant stimulation. The rate of downregulation is dose-dependent. Higher doses and more frequent use produce faster and more extensive receptor downregulation.
A study by Hirvonen and colleagues, published in 2012 in Molecular Psychiatry, used PET imaging to show that daily cannabis users had approximately 20% fewer CB1 receptors in cortical brain regions compared to controls.[1] While this study examined flower users, the principle applies with greater force to concentrate users who deliver much higher THC doses per session.
The practical consequence is a familiar pattern: a user starts dabbing because flower no longer produces the desired effect. Concentrates initially produce the intense experience they are seeking. Within weeks to months of regular use, their tolerance has escalated to the point where they need larger dabs or more frequent sessions to achieve the same effect. Flower becomes essentially ineffective. The baseline has shifted.
This tolerance escalation is not just about needing more to get high. It also means that withdrawal symptoms, when they occur, tend to be more severe. Users transitioning from heavy concentrate use report more intense insomnia, anxiety, irritability, appetite loss, and mood disturbances than those coming from flower use alone. For more on this pattern, see dab and concentrate addiction and withdrawal.
Dependence Risk
Cannabis use disorder affects an estimated 9% of all cannabis users and approximately 17% of those who begin in adolescence, according to a widely cited estimate by Anthony and colleagues (1994) and subsequent reviews. These statistics predate the widespread availability of high-potency concentrates.
While no large epidemiological studies have specifically measured the dependence rate among exclusive concentrate users, the pharmacological principles are well-established: higher doses, faster onset, and more frequent use are all risk factors for developing substance dependence with any psychoactive drug. Concentrates deliver on all three dimensions.
A 2019 study by Chan and colleagues in Drug and Alcohol Dependence found that concentrate users reported significantly higher tolerance, greater withdrawal severity, and more frequent use compared to flower-only users. The study was cross-sectional and could not establish causation (people predisposed to heavier use may self-select into concentrate use), but the pattern is consistent with what pharmacology would predict.
Harm Reduction for Dabbing
If you choose to dab, these practices can reduce some of the associated risks.
Use temperature-controlled devices. Keep the temperature below 450 degrees Fahrenheit to minimize harmful byproduct formation. E-nails and regulated portable devices make this easier than torch-and-nail setups.
Purchase from regulated sources. Lab-tested concentrates from licensed dispensaries are less likely to contain residual solvents, pesticides, or adulterants. Check the certificate of analysis.
Limit frequency. Daily dabbing accelerates tolerance and increases dependence risk. Using concentrates as an occasional rather than default consumption method helps moderate these risks.
Take tolerance breaks. If you notice that your tolerance has escalated significantly, a structured tolerance break can partially reverse CB1 receptor downregulation. The process takes approximately 2 to 4 weeks for meaningful receptor recovery. See cannabis tolerance break guide for a detailed approach.
Monitor your relationship with the substance. If you are using concentrates because flower no longer works, that is a sign of significant tolerance development. If you experience distress when you cannot dab, that suggests psychological or physical dependence. If your use is interfering with work, relationships, or health, consider whether your consumption pattern is serving you.
The Bottom Line
Dabbing is an efficient way to consume cannabis that delivers potent effects quickly. It also delivers higher THC doses that accelerate tolerance development, may increase dependence risk, and can produce harmful compounds at high temperatures. The technology has outpaced the research, meaning we know more about the pharmacological principles than the specific long-term outcomes.
Understanding the temperature science, the tolerance implications, and the dependence risk allows you to make informed decisions. Whether you choose to dab, how frequently, and at what temperature are decisions that should be based on this information rather than on the assumption that a legal product is automatically a safe one.
The Bottom Line
Comprehensive guide to dabbing mechanics, pharmacology, and risks. Mechanism: flash vaporization of concentrates (60-90% THC) on heated surface via dab rig, e-nail, or portable device; delivers THC dose equivalent to entire joint in single breath; peak blood levels within 1-3 minutes. Concentrate types: shatter (70-90% THC, glass-like), wax/budder (similar potency, different texture), live resin (60-80% THC, higher terpenes from fresh-frozen), rosin (solventless), distillate (90%+ THC, stripped of terpenes). Temperature science: low temp (300-450°F) = smooth, flavorful, fewer byproducts; medium (450-600°F) = more intense; high (600°F+) = 2017 Meehan-Atrash ACS Omega found methacrolein and benzene formation from terpene degradation. Pharmacokinetics: 2017 Bidwell — concentrate users had roughly double blood THC levels vs flower users but reported similar intoxication (rapid tolerance compensation). Tolerance: CB1 downregulation is dose-dependent; Hirvonen 2012 Molecular Psychiatry PET imaging: daily users had ~20% fewer cortical CB1 receptors; concentrate use accelerates this, making flower ineffective. Dependence: 2019 Chan Drug and Alcohol Dependence — concentrate users had higher tolerance, worse withdrawal, more frequent use than flower-only. EVALI: 2019 outbreak from vitamin E acetate in illicit vape carts, not flower-based concentrates. Harm reduction: temp-controlled devices, regulated sources, limit frequency, tolerance breaks.
Frequently Asked Questions
Sources & References
- 1RTHC-00573·Hirvonen, Jussi et al. (2012). “Daily Cannabis Use Was Linked to Fewer CB1 Receptors. A Month Without Brought Them Back..” Molecular Psychiatry.Study breakdown →PubMed →↩
Research Behind This Article
Showing the 8 most relevant studies from our research database.
Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.
Newmeyer, Matthew N · 2016
Researchers gave the same dose of cannabis to both frequent and occasional users through three routes: smoking, vaporizing, and eating.
Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes.
Vandrey, Ryan · 2017
Six healthy adults per dose received cannabis brownies containing 10, 25, or 50 mg THC, with specimens collected for 9 days. Blood THC concentrations were remarkably low: mean peak levels were only 1, 3.5, and 3.3 ng/mL for the three doses, far lower than levels seen after smoking.
Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state.
Smart, Rosanna · 2017
Analyzing Washington State's cannabis traceability data from July 2014 to September 2016 (over 44 million purchases), the study revealed several market trends. Traditional cannabis flower still dominated at 66.6% of spending, but extracts for inhalation (concentrates) grew by 145.8% in market share, reaching 21.2% of sales.
Potency trends of delta9-THC and other cannabinoids in confiscated marijuana from 1980-1997.
ElSohly, M A · 2000
Researchers analyzed 35,312 cannabis preparations confiscated in the United States between 1980 and 1997, categorizing them as marijuana, sinsemilla, hashish, hash oil, Thai sticks, or ditchweed. More than 82% of confiscated samples were marijuana in every year.
"Residual blood THC levels in frequent cannabis users after over four hours of abstinence: A systematic review.".
Peng, Yuan Wei · 2020
Across 6 independent studies, frequent cannabis users showed blood THC above 2 ng/mL (or plasma THC above 3 ng/mL) after six days of abstinence in 5 studies.
Nonsmoker Exposure to Secondhand Cannabis Smoke. III. Oral Fluid and Blood Drug Concentrations and Corresponding Subjective Effects.
Cone, Edward J · 2015
Six non-smokers sat alternately with six cannabis smokers in a sealed chamber for one hour across three sessions.
Non-smoker exposure to secondhand cannabis smoke. I. Urine screening and confirmation results.
Cone, Edward J · 2015
Six non-smokers were exposed to secondhand cannabis smoke in a sealed chamber with six smokers for one hour across three sessions.
Non-smoker exposure to secondhand cannabis smoke II: Effect of room ventilation on the physiological, subjective, and behavioral/cognitive effects.
Herrmann, Evan S · 2015
Non-cannabis-using individuals were exposed to secondhand smoke from six people smoking 11.3% THC cannabis in a sealed chamber for one hour under two conditions: unventilated and ventilated (11 air exchanges per hour). Unventilated exposure produced detectable THC in blood and urine, minor heart rate increases, mild-to-moderate self-reported sedation, and impaired performance on a cognitive task (digit symbol substitution).